Biote Corp

NAS:BTMDHealthcarenasdaq_composite

$1.07−1.83%LiveIn session · ≈ AED 3.93 · Market cap $38.44M · Next earnings Wed 4 Nov

BTMD · Income statement · TradingHolo

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	116.6	139.4	165.0	185.4	197.2	192.2	183.5	−4.5%
Cost of revenue	44.9	48.8	54.6	57.9	58.1	54.9	59.9	+9.2%
Gross profit	71.6	90.6	110.4	127.5	139.1	137.4	123.6	−10.0%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	37.4	54.0	171.1	98.8	107.5	101.8	—	—
Selling & marketing	4.4	4.9	0.0	0.0	0.0	0.0	—	—
Operating expenses	39.9	56.0	171.1	98.8	107.5	101.8	—	—
Operating income	31.8	34.6	(60.7)	28.7	31.6	35.6	14.8	−58.5%
Interest expense	2.4	1.7	4.0	6.4	11.0	11.0	9.4	−14.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	(2.4)	(1.7)	62.4	(28.8)	(30.6)	2.0	—	—
Pre-tax income	29.4	32.9	1.7	(0.1)	1.0	37.6	10.3	−72.7%
Income tax	0.2	0.3	0.4	2.7	1.0	6.0	3.2	−46.9%
Net income	29.2	32.6	(1.0)	3.3	3.2	27.0	5.9	−78.3%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	3.85	(0.87)	0.16	0.13	0.09	0.86	0.17	−80.5%
EPS, diluted (per share)	3.85	(0.87)	0.16	0.13	0.09	0.74	0.12	−84.2%
EBITDA	32.9	36.0	8.0	39.5	15.6	52.2	20.7	−60.3%
Depreciation & amortization	1.1	1.4	2.2	0.8	3.6	3.7	3.8	+4.8%
Weighted average shares (shares)	7,574,271	7,574,271	8,059,371	25,709,343	34,270,809	31,283,245	—	—
Weighted average diluted shares (shares)	7,574,271	7,574,271	8,059,371	25,709,343	34,270,809	36,666,766	—	—
Gross margin	61.5%	65.0%	66.9%	68.8%	70.5%	71.5%	67.4%	−4.1 pts
Operating margin	27.3%	24.8%	−36.8%	15.5%	16.0%	18.5%	8.0%	−10.5 pts
Net margin	25.0%	23.4%	−0.6%	1.8%	1.6%	14.1%	3.2%	−10.9 pts

USD millionsUpdated Fri 7 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.